KR20170117841A - Improvement or treatment of atopic dermatitis using a purified composition obtained from raw ore powder and charcoal powder - Google Patents
Improvement or treatment of atopic dermatitis using a purified composition obtained from raw ore powder and charcoal powder Download PDFInfo
- Publication number
- KR20170117841A KR20170117841A KR1020160045791A KR20160045791A KR20170117841A KR 20170117841 A KR20170117841 A KR 20170117841A KR 1020160045791 A KR1020160045791 A KR 1020160045791A KR 20160045791 A KR20160045791 A KR 20160045791A KR 20170117841 A KR20170117841 A KR 20170117841A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- extract
- atopic dermatitis
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 아토피 피부염 개선 또는 치료용 조성물에 관한 것으로, 보다 상세하게는 천연재료인 광물과 식물 추출물을 이용하여 과민성 반응을 억제하고, 피부 알레르기 및 친환경성에 따른 피부 진정효과에 따른 아토피 피부염 개선효과를 증대시킨 생광석분말과 숯분말로부터 얻은 정제수를 이용한 아토피 피부염 개선 또는 치료용 조성물에 관한 것이다.The present invention relates to a composition for improving or treating atopic dermatitis, and more particularly, it relates to a composition for improving or treating atopic dermatitis, and more particularly, to a composition for preventing or treating atopic dermatitis by suppressing an hypersensitivity reaction using minerals and plant extracts, And to a composition for improving or treating atopic dermatitis using purified water obtained from an increased raw ore powder and charcoal powder.
Description
본 발명은 아토피 피부염 개선 또는 치료용 조성물에 관한 것으로, 보다 상세하게는 천연재료인 광물과 식물 추출물을 이용하여 과민성 반응을 억제하고, 피부 알레르기 및 친환경성에 따른 피부 진정효과에 따른 아토피 피부염 개선효과를 증대시킨 생광석분말과 숯분말로부터 얻은 정제수를 이용한 아토피 피부염 개선 또는 치료용 조성물에 관한 것이다.The present invention relates to a composition for improving or treating atopic dermatitis, and more particularly, it relates to a composition for improving or treating atopic dermatitis, and more particularly, to a composition for preventing or treating atopic dermatitis by suppressing an hypersensitivity reaction using minerals and plant extracts, And to a composition for improving or treating atopic dermatitis using purified water obtained from an increased raw ore powder and charcoal powder.
잘 알려진 바와 같이, 아토피 피부염은 대부분 유아기나 소아 때 발생하여 호전과 악화를 반복하며 외부 자극 물질에 의해 발진과 심한 가려움을 수반하는 만성 염증성 피부질환이다. As is well known, atopic dermatitis is a chronic inflammatory skin disease that occurs most often during infancy and childhood, which is repeated with aggravation and aggravation, accompanied by rash and severe itching by external stimulants.
산업의 발달과 함께 가속화된 도시화와 산업화는 환경오염을 야기하게 되었고, 이러한 환경오염은 아토피성 피부염 발생을 급격히 증가시켜 심각한 사회문제로까지 번지고 있다.Accelerated urbanization and industrialization, along with the development of industry, have caused environmental pollution, and this environmental pollution has rapidly spread to the occurrence of atopic dermatitis and has become a serious social problem.
이러한 아토피 피부염의 병인론은 아직 확실히 밝혀 있지 않지만, IgE 항체의 증가에 따른 과감작 반응에 의하거나, 세포매개성 면역기능의 저하로 나타나는 T 림프구의 불균열 분화에 의한 기능적 결여와 같은 병리적 요인이 밝혀지면서 현재 면역학적인 이상이 관여하는 질환으로 생각되고 있다.The pathogenesis of atopic dermatitis has not yet been elucidated. However, the pathogenesis of atopic dermatitis has not yet been elucidated. However, pathological factors such as a hypersensitivity reaction due to an increase in IgE antibody or a functional deficiency due to a cracking differentiation of T lymphocytes, It is now thought to be a disease in which immunological abnormalities are involved.
또한, 아토피 피부염의 대부분을 차지하는 외인성 아토피 피부염은 IgE와 연관된 면역기전에 의해 발생되는데 특정 allergen에 대한 즉시형 면역반응보다는 T세포 이상에 의한 지연성 면역 반응이 관여한다는 보고들이 많다.In addition, it is reported that extrinsic atopic dermatitis, which accounts for most of atopic dermatitis, is caused by IgE-related immune mechanism, and delayed immune response due to T-cell abnormality is involved rather than immediate type immune response to specific allergens.
최근에는 B세포로부터 IgE의 생성을 유도하는 Il-4등 Th2 관련 cytokine들이 아토피의 원인이라고 보고되고 있다(JS Kang et al., Inhibition of atopic dermatitis by topical application of silymarin in NC/Nga mice. Intl Immunopharm. (2008) 8. 1475-1480).Recently, Th2-related cytokines such as IL-4, which induce IgE production from B cells, have been reported to be the cause of atopy (JS Kang et al., Inhibition of atopic dermatitis by topical application of silymarin in NC / Nga mice. Intl Immunopharm (2008) 8 1475-1480).
한편, 아토피 피부염의 개선, 치료 및 관리를 위해 피부 표면의 수분을 유지시켜주는 보습제와 염증반응을 호전시키기 위한 스테로이드 호르몬 즉, 국소 부신피질호르몬 제제를 처방하는 하는 것이 일반적이다.Meanwhile, in order to improve, treat and manage atopic dermatitis, it is common to prescribe a moisturizing agent that maintains moisture on the surface of the skin and a steroid hormone, that is, a topical corticosteroid preparation, to improve the inflammatory reaction.
하지만, 국소 부신피질호르몬의 경우 피부 위축, 혈관 확장, 색소 탈실 및 팽창 선조의 발생 등 다양한 피부 부작용을 야기하는 문제가 있어 장기간 사용하기에 무리가 있다.However, local adrenocortical hormone is troublesome for long-term use because it causes various skin side effects such as skin atrophy, vasodilatation, pigment desalination, and swelling ancestry.
따라서, 항아토피 효능을 가진 동시에 부작용이 매우 낮은 천연 신약 후보물질을 이용한 아토피 치료제 또는 보조 물질로의 개발이 제약, 화장품 영역에서 진행되고 있으나 다양한 임상실험과 개발기간이 길고, 아직까지 이렇다할 치료제가 개시되지 못하고 있다.Therefore, the development of atopic treatments or adjuvants using natural candidate substances with anti-atopic efficacy and very low side effects is proceeding in the fields of pharmaceuticals and cosmetics, but various clinical experiments and development periods are long, .
이에, 하기와 같은 다양한 치료 보조기능을 갖는 아토피 피부염 개선 또는 완화, 나아가 치료 효과까지 얻을 수 있는 천연재료를 이용한 조성물들이 개시되고 있다.Accordingly, compositions using natural materials capable of improving or alleviating atopic dermatitis having various therapeutic-auxiliary functions as described below, and further obtaining therapeutic effects, have been disclosed.
본 발명은 상술한 바와 같은 종래 기술상의 제반 문제점들을 감안하여 이를 해결하고자 창출된 것으로, 천연재료인 광물과 식물 추출물을 이용하여 과민성 반응을 억제하고, 피부 알레르기 및 친환경성에 따른 피부 진정효과에 따른 아토피 피부염 개선효과를 증대시킨 생광석분말과 숯분말로부터 얻은 정제수를 이용한 아토피 피부염 개선 또는 치료용 조성물을 제공함에 그 주된 목적이 있다.DISCLOSURE OF THE INVENTION The present invention has been made in view of the above-described problems in the prior art, and it is an object of the present invention to provide a cosmetic composition which suppresses the hypersensitivity reaction by using minerals and plant extracts which are natural materials, And a composition for improving or treating atopic dermatitis using purified water obtained from a raw ore powder and a charcoal powder that have improved dermatitis improving effect.
본 발명은 상기한 목적을 달성하기 위한 수단으로, 0.1-0.3mm의 입도로 분쇄하여 얻은 생광석분말과 물을 7:3의 중량비로 혼합한 상태에서 증발시켜 증류수를 얻고, 이 증류수를 0.1-0.2cm의 입도를 갖는 숯분말에 여과시켜 얻은 정제수와; 상기 정제수 100중량부에 대해, 카렌듈라 추출액 5-8중량부, 흰목이버섯 엑기스 4-6중량부, 느릅 추출액 3-5중량부, 녹차 추출액 5-8중량부, 산해박 추출액 3-5중량부, 아모디메치콘 6-10중량부, 닥나무 추출액 3-6중량부, 소듐피씨에이 6-10중량부, 하이알루로닉애씨드 3-6중량부, 눈괴불주머니 추출액 4-8중량부를 포함하여 조성된 것을 특징으로 하는 생광석분말과 숯분말로부터 얻은 정제수를 이용한 아토피 피부염 개선 또는 치료용 조성물을 제공한다.As a means for achieving the above-mentioned object, the present invention provides a method for separating a raw ore powder obtained by grinding a raw ore powder having a particle size of 0.1-0.3 mm and water at a weight ratio of 7: 3 in a mixed state to obtain distilled water, Purified water obtained by filtration through a charcoal powder having a particle size of 0.2 cm; 5-8 parts by weight of calendula extract, 4-6 parts by weight of white mushroom extract, 3-5 parts by weight of elm extract, 5-8 parts by weight of green tea extract, 3-5 parts by weight of an acidic sea extract, 6 to 10 parts by weight of an amodimethicone, 3-6 parts by weight of a mulberry extract, 6 to 10 parts by weight of sodium pcine, 3-6 parts by weight of hyaluronic acid and 4-8 parts by weight of an extract of snowballs The present invention also provides a composition for improving or treating atopic dermatitis using purified water obtained from raw ore powder and charcoal powder.
이때, 상기 정제수 100중량부에 대해 알란토인(Allantoin)을 5-10중량부 더 첨가한 것에도 그 특징이 있다.At this time, 5-10 parts by weight of allantoin is added to 100 parts by weight of the purified water.
또한, 상기 정제수 100중량부에 대해 꽃다지 추출액을 4-8중량부 더 첨가한 것에도 그 특징이 있다.Further, the present invention is also characterized in that 4-8 parts by weight of flower extract is added to 100 parts by weight of the purified water.
본 발명에 따르면, 인체에 무해함에 반해 오히려 유익한 천연재료들을 이용하여 아토피 치료 개선에 효과적인 기능성 조성물을 제공함으로써 피부 알레르기 반응도 없고, 피부 진정효과가 뛰어나 저렴한 비용으로 아토피 치료 개선에 기여하는 효과를 얻을 수 있다.According to the present invention, by providing a functional composition effective for improvement of atopic treatment by using natural materials which are harmless to the human body rather than being harmless to the human body, there is no skin allergy reaction, have.
이하에서는, 본 발명에 따른 바람직한 실시예를 보다 상세하게 설명하기로 한다.Hereinafter, preferred embodiments according to the present invention will be described in detail.
본 발명 설명에 앞서, 이하의 특정한 구조 내지 기능적 설명들은 단지 본 발명의 개념에 따른 실시예를 설명하기 위한 목적으로 예시된 것으로, 본 발명의 개념에 따른 실시예들은 다양한 형태로 실시될 수 있으며, 본 명세서에 설명된 실시예들에 한정되는 것으로 해석되어서는 아니된다.Before describing the present invention, the following specific structural or functional descriptions are merely illustrative for the purpose of describing an embodiment according to the concept of the present invention, and embodiments according to the concept of the present invention may be embodied in various forms, And should not be construed as limited to the embodiments described herein.
또한, 본 발명의 개념에 따른 실시예는 다양한 변경을 가할 수 있고 여러 가지 형태를 가질 수 있으므로, 본 발명의 사상 및 기술 범위에 포함되는 모든 변경물, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.In addition, it should be understood that the embodiments according to the concept of the present invention include various modifications, equivalents, and alternatives included in the spirit and technical scope of the present invention, .
본 발명에 따른 생광석분말과 숯분말로부터 얻은 정제수를 이용한 아토피 피부염 개선 또는 치료용 조성물은 정제수가 아주 중요한 구성 중 하나인데, 이는 액상으로 제조하여 피부에 직접 스프레이할 수 있도록 구성되는 조성물이기 때문에 천연재료들을 잘 배합하여 각기 고유의 특성을 그대로 발현시키면서 정제수 자체로도 피부 진정 효과를 얻을 수 있으면서 피부에 안정적으로 고착상태를 유지할 수 있어야 하기 때문이다.The composition for improving or treating atopic dermatitis using purified water obtained from raw ore powder and charcoal powder according to the present invention is one of very important constituents because it is made into a liquid form and can be sprayed directly onto the skin, It is necessary to be able to maintain the fixed state of the skin stably while being able to obtain the soothing effect of the purified water itself, while manifesting the unique characteristics of each material by well mixing the ingredients.
이를 위해, 본 발명에서는 기본 베이스가 되는 정제수를 생광석분말과 숯분말로부터 얻은 물을 사용한다.To this end, in the present invention, purified water serving as a basic base is used as raw ore powder and water obtained from charcoal powder.
여기에서, 생광석분말은 생광석(raw ore)을 0.1-0.3mm의 입도로 분쇄하여 얻을 수 있으며, 생광석은 강원도 영월에서 채취되는 광석이다.Here, the raw ore powder can be obtained by pulverizing raw ore with a particle size of 0.1-0.3 mm, and the raw ore is an ore collected from Youngwol in Gangwon-do.
이러한 생광석은 생명체에 유익한 8~12㎛ 파장대의 원적외선을 방출하는 광물로서, 특히 강원도 영월에서 채취된 돌은 자원연구소의 분자구조분석 결과 세계에서 유일한 돌로 판정되어 생광석(生光石)이란 새로운 이름으로 불리우고 있다.This stone is a mineral that emits far infrared rays in the wavelength range of 8 ~ 12 ㎛ which is beneficial for life. In particular, the stone taken from Yeongwol, Gangwon province is determined as the only stone in the world as a result of the molecular structure analysis by the resource research institute. .
이와 같은 생광석은 다른 광석과는 전혀 다른 특수한 구조체로서 암석 내부에 기공이 없이 생체세포 활성화에너지를 방사하고 있어 이 생체세포 활성화에너지에 의해 공기중의 수분이 단분자 이온화하여 히드록시 음이온을 생성하거나 산소에 음이온을 띠게 함으로써 반영구적으로 음이온 효과를 제공하는 것으로 알려져 있다.This kind of biotite is a special structure which is completely different from other ore, and it emits bio-cell activation energy without pore inside the rock, so that the water in the air is monomolecularly ionized by the bio-cell activation energy to generate hydroxy anion It is known to provide anion effect semi-permanently by applying anion to oxygen.
또한, 인간의 생체세포에 직접적으로 반응하여 생체가 갖고 있는 물분자의 공명현상과 세포분자의 진동현상으로 체온을 상승시켜 발한효과(땀을 내는 효과)를 주며, 이에 의해 생체에 매우 유익한 효과를 제공하는 것으로 알려져 있다.In addition, by directly reacting with human living cells, resonance phenomenon of water molecule of living body and vibration phenomenon of cell molecules elevate body temperature to give a sweating effect (sweat effect), thereby giving a very beneficial effect to the living body .
특히, 본 출원인은 상기 생광석을 달구면 활성화가 더욱 촉진되어 다량의 원적외선도 방출한다는 사실을 발견하였기에 이를 더욱 더 촉진하기 위해 생광석을 분말화시킨 후에 물에 넣고 약 800-900℃로 4-8시간 정도 끓여 기화되는 증기를 포집하고 이를 냉각하여 증류수를 만들었다.In particular, the Applicant has discovered that the activated ores are more activated and emit a large amount of far-infrared rays. To further facilitate this, the raw ore is pulverized, and then water is added thereto at a temperature of about 800-900 ° C to form 4- After boiling for about 8 hours, steam was collected and cooled to make distilled water.
이때, 상기 물과 생광석분말의 비율을 3:7의 중량비를 유지하였으며, 물이 증발되어 포집되면 그 만큼씩 동일량의 물을 보충하면서 가열하였고, 부식 방지를 위해 물은 철분기가 없는 물을 사용하였다.At this time, the ratio of the water to the raw ore powder was maintained at a weight ratio of 3: 7. When the water was evaporated and collected, the same amount of water was supplemented while heating the water. Respectively.
그리고, 이렇게 하여 얻은 증류수를 쌀알 반정도 크기인 0.1-0.2cm의 입도를 갖는 숯분말이 담긴 통에 여과시켜 본 발명에서 사용하는 정제수를 얻었다.The distilled water thus obtained was filtered through a barrel containing charcoal powder having a grain size of 0.1-0.2 cm, which is half the size of rice grain, to obtain purified water used in the present invention.
이와 같은 방식으로 정제수를 얻음으로서 정제수 자체로서 자정능력은 물론 세포 진정효과를 갖는 활성화수로서의 기능을 갖도록 구성하였다.By obtaining purified water in this manner, the purified water itself is configured to have not only the self-purification ability but also the function as the activated water having the cell sedative effect.
본 발명에 따른 조성물은 상술한 방법에 의해 얻은 정제수와, 상기 정제수 100중량부에 대해 카렌듈라 추출액 5-8중량부, 흰목이버섯 엑기스 4-6중량부, 느릅 추출액 3-5중량부, 녹차 추출액 5-8중량부, 산해박 추출액 3-5중량부, 아모디메치콘 6-10중량부, 닥나무 추출액 3-6중량부, 소듐피씨에이 6-10중량부, 하이알루로닉애씨드 3-6중량부, 눈괴불주머니 추출액 4-8중량부를 포함하여 구성된다.The composition according to the present invention comprises purified water obtained by the above-mentioned method and 5-8 parts by weight of calendula extract, 4-6 parts by weight of white mushroom extract, 3-5 parts by weight of elm extract, 5-8 parts by weight of an acidic sea bream extract, 3-5 parts by weight of an acidic sea bream extract, 6-10 parts by weight of amodimethicone, 3-6 parts by weight of a mackerel extract, 6-10 parts by weight of sodium PCAE, 3-6 parts by weight of hyaluronic acid 3-6 And 4 to 8 parts by weight of an eyeball collagen extract.
이때, 상기 카렌듈라 추출액은 주로 소화기와 호흡기 질환에 약제로 사용되던 카렌듈라 잎을 이온수와 함께 탕조에 넣고 쪄서 추출한 추출액을 사용하며, 피부를 진정시키는 효과를 얻기 위해 본 발명에서 첨가되고, 독특한 냄새 때문에 5-8중량부로 한정하여 첨가된다.At this time, the above-mentioned Calendula extract is added in the present invention in order to obtain an effect of soothing the skin, by using an extract obtained by putting calendula leaf which has been mainly used as a medicine for digestive and respiratory diseases in a hot water tank together with ionized water. -8 parts by weight.
또한, 상기 흰목이버섯 엑기스는 면역력 강화에 효과적이며, 건조하고 아토피성 피부에는 다당류 함유량이 많아 손상된 세포들을 재생,회복시키므로 노화방지, 보습 효능을 발휘한다.In addition, the white mushroom extract is effective for enhancing the immunity, and the dry and atopic skin has a large polysaccharide content, thereby regenerating and repairing damaged cells, thereby exhibiting anti-aging and moisturizing effects.
더구나, 비타민D가 표고버섯보다 20배 더 많이 함유되어 있기 때문에 피부에 영양을 공급하는 효과를 제공한다.Moreover, because vitamin D is 20 times more abundant than shiitake mushrooms, it provides nutritional benefits to the skin.
이러한 흰목이버섯 엑기스는 흰목이버섯을 채취한 뒤 엑기스로 만들어 첨가되며 6중량부를 초과하면 점도를 증가시키고, 4중량부 미만으로 첨가되면 면역력 강화, 피부 재생 효과가 떨어지므로 상기 범위로 한정하여야 한다.When the amount of the mushroom extract is less than 4 parts by weight, the effect of enhancing the immunity and the effect of regenerating the skin are deteriorated. Therefore, the amount of the mushroom extract should be limited to the above range .
그리고, 상기 느릅 추출액은 유근피를 발효시켜 얻은 추출액을 사용하되 타닌이 포함되어 있어 피부 내부의 열과 독소 배출에 효능이 있으며, 과량 사용시 피부 산성화를 초래할 수 있으므로 상기 범위로 한정해야 한다.In addition, the elm extract may be used in an extract obtained by fermenting rhizome, but it is effective in releasing heat and toxins inside the skin because it contains tannin, and it may cause acidification of skin when used excessively.
뿐만 아니라, 상기 녹차 추출액은 녹차잎으로부터 추출된 액을 사용하며, 녹차를 차로 복용하였을 때는 정신적인 활력을 주어 기분을 상쾌하게 만들어 주고 각종 세균의 성장을 억제하며 중독과 감기를 예방하여 식후의 차는 입안 세균의 번식을 억제하는 효과가 있으나, 본 발명에서는 추출액 형태로 스프레이 가능하게 구성함으로써 독성물질을 분해 배설시키는 효능을 얻도록 한다.In addition, the green tea extract uses a liquid extracted from green tea leaf. When tea is taken as a tea, it gives mental vitality to refresh the mood, suppresses the growth of various bacteria, prevents poisoning and cold, In the present invention, by spraying in the form of an extract, the effect of decomposing and extinguishing toxic substances is obtained.
이것은 녹차에 함유된 폴리페놀 성분이 풍부하기 때문인 것으로 알려져 있으며, 녹차 속 카테킨이 몸속 중금속이나 니코틴과 결합해 체외로 배출하는 효과가 있으며 음식을 과다섭취해 쌓이는 글리코겐을 분해해 신진대사를 촉진시켜 주어 체중을 줄이는 비만방지 효과까지 있다고 보고되어 있다.It is known to be due to the abundance of polyphenols contained in green tea. Catechin in green tea is combined with heavy metals and nicotine in the body to excrete to the outside of the body. It over-consumes food and digests glycogen to accelerate metabolism. It has also been reported to reduce weight and prevent obesity.
특히, 본 발명에서는 독소 물질 배출로 피부 트러블 방지를 위해 첨가되며, 5중량부 미만으로 첨가되면 트러블 방지, 피부 짖무름 방지 특성을 기대하기 어렵고, 8중량부를 피부 점착특성을 떨어뜨리므로 상기 범위로 한정해야 한다.Particularly, in the present invention, it is added in order to prevent skin troubles due to the release of toxic substances, and if it is added in an amount of less than 5 parts by weight, it is difficult to prevent trouble and skin irritation, It should be limited.
아울러, 상기 산해박(Cynanchum paniculatum) 추출액은 진정작용을 강화하기 위해 녹차 추출액과 함께 첨가된다.In addition, the above-mentioned Cynanchum paniculatum extract is added together with green tea extract to enhance sedation.
이러한 산해박은 서장경이라고도 하는 박주가리과로 산과 들의 볕이 잘 드는 풀밭에서 자라며, 줄기는 곧게 서고 가늘며 마디 사이가 길고, 개화기는 8∼9월경이며 연한 황갈색을 띠며, 산해박의 뿌리를 한방에서는 서장경(徐長卿)이라는 약재로 쓰는데, 진통·진정·항균 효과가 있는 것으로 알려져 있다.This mountain is known as Sejanggyeong, and it grows in the sunny grasses of the mountains. The stems are straight and thin and long between the nodes. The flowering period is around August to September, light yellowish brown, (Xu Xianglong) is used as a medicinal product, is known to have analgesic, sedative, antibacterial effect.
본 발명에서는 진통 억제 기능을 구현하기 위해 첨가되는 것이므로 과량 첨가할 필요는 없으며, 상기 범위로 첨가되어야 한다.In the present invention, it is added in order to implement an analgesic function, and therefore it is not necessary to add an excessive amount, and it should be added within the above range.
또한, 상기 아모디메치콘은 실리콘 오일의 일종으로서, 본 발명에 따른 정제수가 약제 성분을 끌고 피부로 침투할 때 피부표면에 침착되어 흘러내리 않게 고착시켜 부착성을 향상시키기 위해 첨가되며, 특히 첨가 성분들의 분산성을 증대시키는 기능을 위해 6-10중량부의 범위 내에서 첨가된다.In addition, the above-mentioned amodimicecone is a kind of silicone oil, and purified water according to the present invention is added in order to attract the pharmaceutical ingredient and penetrate into the skin, so as to deposit on the skin surface, Is added in a range of 6 to 10 parts by weight for a function of increasing the dispersibility of the components.
그리고, 상기 닥나무 추출액은 닥나무 잎으로부터 추출되는 천연 추출물로서, 닥나무 잎은 예로부터 피부병과 피부재생작용, 지혈작용에 효과가 뛰어나 피부질환 치료에 활용하였음은 알려져 있는 사실이고, 현대에서도 과학적 분석을 통해 카지놀과 글리코사이드, 페놀류, 유기산, 탄닌, 플라보노이드 등 20여가지 성분이 함유되어 있어 아토피 치료에 효과가 있는 것으로 보고되어 있다.It is known that the mackerel extract is a natural extract extracted from the mackerel leaves. The mackerel leaves have been known to have excellent effects on skin diseases, skin regeneration and hemostasis, and have been used for treating skin diseases. It has been reported that it contains 20 kinds of ingredients such as casinol, glycosides, phenols, organic acids, tannins, and flavonoids and is effective for treating atopy.
본 발명에서는 닥나무 잎으로부터 추출액을 추출할 때 닥나무 잎과 뿌리를 80:20의 중량비로 솥에 넣고 찐 다음 여과시켜 얻은 것을 3-6중량부 범위 내에서 첨가한다.In the present invention, when extracting the extract from a mulberry leaf, the mulberry leaves and roots are put into a pot at a weight ratio of 80:20, and the resultant is filtered and added within a range of 3-6 parts by weight.
아울러, 상기 소듐피씨에이는 피부 보습을 위해 첨가되는 성분으로서, 보습을 적절히 유지시켜 가려움증을 억제하고, 아토피에 따른 발진을 진정시키는 기능을 담당하게 된다.In addition, the sodium pcine is added to moisturize the skin. It keeps moisturizing properly, suppresses itching, and calms the rash caused by atopy.
또한, 상기 하이알루로닉애씨드(hyaluronic acid)는 피부를 보호하기 위해 3-6중량부 범위 내에서 첨가되는데, 상기 하이알루로닉애씨드는 피부 면역력을 강화하고, 해독하여 피부트러블을 최소화시킴으로써 아토피 활성화를 억제하는 특성을 갖는다.In addition, the hyaluronic acid is added in a range of 3-6 parts by weight to protect the skin. The hyaluronic acid enhances skin immunity and detoxifies to minimize skin troubles, And has the property of inhibiting activation.
특히, 상기 하이알루로닉애씨드는 Ν-아세칠글코사민산(N-acetylglucosamic acid)이 상호 직쇄상로 결합한 산성고분자 다당체로서 점액성 윤활작용을 하는 외에 조직의 수분대사나 구조의 유지를 담당하며 또 세균의 침입에 대한 방어기능을 하고 하이알루로니다아제(hyalouronidase)에 의해서 분해되는 물질이다.Particularly, the above-mentioned hyaluronic acid is an acidic polysaccharide in which N-acetylglucosamic acid is bonded to each other in a straight-chain manner, and is responsible for maintaining the moisture metabolism and structure of the tissue in addition to mucous lubrication It is a substance that defends against the invasion of bacteria and is degraded by hyaluronidase.
뿐만 아니라, 상기 눈괴불주머니 추출액은 4-8중량부 범위에서 더 첨가할 수 있는데, 눈괴불주머니는 1년 또는 2년생 초본으로 종자로 번식하며, 독성이 있어 먹으면 호흡곤란, 심장마비 등이 일어나지만, 피부에 발랐을 때는 진통, 청열해독, 타박상 완화 기능을 수행한다.In addition, the above-mentioned snowball pocket extract can be added in the range of 4-8 parts by weight. The snowball pocket is one year or two year old and grows as a seed. When it is toxic, it causes dyspnea and heart attack When it is applied to the skin, it performs pain relief, detoxification, and bruising relief.
덧붙여, 본 발명에 따른 조성물에는 피부의 진정 및 완화 작용을 하므로 피부트러블을 방지 효능을 더욱 강화하기 위해 알란토인(Allantoin)을 상기 정제수 100중량부에 대해 5-10중량부 더 첨가할 수 있다.In addition, since the composition according to the present invention has a soothing and alleviating action of the skin, allantoin may be added in an amount of 5 to 10 parts by weight based on 100 parts by weight of the purified water, in order to further enhance the effect of preventing skin troubles.
이때, 상기 알란토인(Allantoin)은 상수리나무 컴프리뿌리와 사탕무, 밀의 싹과 같은 곳에서 추출되어지는 천연물질이다.At this time, the allantoin is a natural substance extracted from places such as oat flour, beetroot, wheat germ, and the like.
뿐만 아니라, 본 발명에 따른 조성물에는 피부에 영양을 공급하여 피부 부풀어오름과 통증을 억제하고 완화시키기 위해 상기 정제수 100중량부에 대해 꽃다지 추출액을 4-8중량부 더 첨가할 수 있다.In addition, 4-8 parts by weight of flower extract may be added to 100 parts by weight of the purified water in order to nourish the skin to suppress skin swelling and pain, and to alleviate pain.
이때, 상기 꽃다지는 십자화과에 속하는 2년생 식물로서, 고래로부터 어린 순은 나물로 먹고 국 끓여 먹는데 사용하여 왔으며, 기침, 가래를 없애고 몸의 붓기를 제거하는데 약제로 사용되어 왔다.At this time, the flower bud is a biennial plant belonging to the cruciferous family. It has been used as a juice from a whale, and has been used as a medicine to remove cough, sputum and swelling of the body.
특히, 꽃다지에는 비타민, 미네랄, 칼슘, 칼륨, 사포닌, 플라보노이드, 폴리페놀이 함유되어 있어 피부에 영양을 공급함은 물론 항산화를 방지하여 통증 및 피부 부풀어오름을 억제하는 효과가 뛰어나므로 본 발명에서는 이로부터 추출된 추출액을 사용한다.In particular, since the flower bud contains vitamins, minerals, calcium, potassium, saponins, flavonoids and polyphenols, it provides nutrition to the skin as well as antioxidant prevention and is excellent in suppressing pain and swelling of the skin. The extracted extract is used.
이러한 조성으로 이루어진 본 발명에 따른 조성물은 첨가물들을 교반기에 넣고 정제수를 부은 다음 40-50℃의 미지근한 상태가 되도록 가열하면서 100-150 알피엠으로 20-30분간 교반하여 완전히 분산시킨 다음 용기에 담아 스프레이 가능한 액상을 유지하도록 구성할 수 있다.The composition according to the present invention composed of this composition is prepared by pouring the additives into a stirrer, pouring the purified water, heating the mixture to 40-50 DEG C in a lukewarm state, stirring the mixture for 20-30 minutes at 100-150 DEG C, So that the liquid phase can be maintained.
이하, 실시예에 대하여 설명한다.Hereinafter, examples will be described.
[실시예 1][Example 1]
본 발명에 따른 조성물이 아토피 치료 개선에 효과가 있는지를 확인하기 위해 상술한 정제수에, 상기 정제수 100중량부에 대하여 카렌듈라 추출액 6중량부, 흰목이버섯 엑기스 5중량부, 느릅 추출액 4중량부, 녹차 추출액 6중량부, 산해박 추출액 4중량부, 아모디메치콘 7중량부, 닥나무 추출액 5중량부, 소듐피씨에이 8중량부, 하이알루로닉애씨드 4중량부, 눈괴불주머니 추출액 6중량부를 포함하도록 하여 조성물을 만들고, 이를 42℃의 미지근한 상태가 되도록 가열하면서 120 알피엠으로 25분간 저어 완전히 분산시킨 다음 용기에 담아 스프레이 가능한 액상의 시료로 만들었다.To confirm whether the composition according to the present invention is effective in improving atopic treatment, 6 parts by weight of calendula extract, 5 parts by weight of white mushroom extract, 4 parts by weight of elm extract, 4 parts by weight of green tea 6 parts by weight of the extract, 4 parts by weight of the acidic sea bream extract, 7 parts by weight of amodimethicone, 5 parts by weight of the extract of mulberry tree, 8 parts by weight of sodium PCA, 4 parts by weight of hyaluronic acid, The mixture was heated to 42 ° C and heated to 120 ° C for 25 minutes to be completely dispersed.
[실시예 2][Example 2]
상기 실시예 1과 동일하게 하되, 상기 정제수 100중량부에 대해 상기 정제수 100중량부에 대해 알란토인(Allantoin)을 8중량부 더 첨가하였다.8 parts by weight of allantoin was added to 100 parts by weight of purified water in the same manner as in Example 1, except that 100 parts by weight of purified water was added.
[실시예 3][Example 3]
상기 실시예 1과 동일하게 하되, 상기 정제수 100중량부에 대해 꽃다지 추출액을 6중량부 더 첨가하였다.In the same manner as in Example 1, 6 parts by weight of flower extract was added to 100 parts by weight of the purified water.
그리고, 상기 실시예1,2,3의 용액에 대해 GC/SIM 분석을 통해 아토피와 관련된 알레르기성 항원(35종)에 대한 분석시험을 실시한 결과, 35종 모두가 불검출되었다.Analysis of the atypical-associated allergic antigens (35 species) by the GC / SIM analysis of the solutions of Examples 1, 2, and 3 was conducted and all 35 species were not detected.
또한, 아토피 염증을 가진 10명의 어린이를 대상으로 염증 부위를 긁고 실시예 1,2,3의 용액을 스프레이한 후 1시간, 2시간, 3시간, 4시간, 5시간이 경과한 시점에서 발진, 홍반, 가려움이 생기는지를 육안으로 확인하는 관능평가를 진행하였다.In addition, 10 children with atopic inflammation rubbed the inflammation site and sprayed the solutions of Examples 1, 2, and 3, and after 1, 2, 3, 4, and 5 hours elapsed, Erythema, and itching were observed.
평가결과, 실시예1의 경우에는 염증이 가라앉는데 걸리는시간이 4시간이었고, 가려움은 발생하지 않았으며, 5시간이 지난 후 홍반이 사라졌고, 따가움이 조금있다고 5명중 2명이 답했다.As a result of evaluation, in Example 1, the time required for inflammation to sink was 4 hours, no itching occurred, and after 5 hours, erythema disappeared and a little bit of stinging was answered.
실시예2의 경우는 염증과 부풀어오름, 통증이 1시간 30분에 사라졌으며, 가려움도 발생하지 않았고, 홍반은 2시간에 사라졌으며, 따가움도 없어 피부 진정효과가 큰 것으로 확인되었다.In the case of Example 2, inflammation, swelling and pain disappeared in 1 hour and 30 minutes, no itching occurred, erythema disappeared in 2 hours, and there was no stinging, indicating that the skin soothing effect was great.
실시예3의 경우는 염증과 부풀어오름, 통증이 3시간에 사라졌으며, 가려움도 발생하지 않았고, 홍반은 4시간이 지난 후에 사라졌으며, 따가움은 없었다.In Example 3, inflammation, swelling and pain disappeared at 3 hours, no itching occurred, and erythema disappeared after 4 hours, and there was no stinging.
이와 같은 평가결과를 통해 본 발명에 따른 조성물이 아토피를 근본적으로 치효할 수는 없지만, 염증 주변을 진정시켜 아토피를 완화시키는데에는 효과가 있는 것으로 확인되었다.From the results of the evaluation, it was confirmed that the composition according to the present invention can not fundamentally effect atopic dermatitis, but is effective for alleviating atopic dermatitis by alleviating inflammation.
Claims (3)
상기 정제수 100중량부에 대해,
카렌듈라 추출액 5-8중량부, 흰목이버섯 엑기스 4-6중량부, 느릅 추출액 3-5중량부, 녹차 추출액 5-8중량부, 산해박 추출액 3-5중량부, 아모디메치콘 6-10중량부, 닥나무 추출액 3-6중량부, 소듐피씨에이 6-10중량부, 하이알루로닉애씨드 3-6중량부, 눈괴불주머니 추출액 4-8중량부를 포함하여 조성된 것을 특징으로 하는 생광석분말과 숯분말로부터 얻은 정제수를 이용한 아토피 피부염 개선 또는 치료용 조성물.
The raw ore powder obtained by pulverization with a particle size of 0.1-0.3 mm and water were mixed at a weight ratio of 7: 3 and evaporated to obtain distilled water. The distilled water was filtered through a charcoal powder having a particle size of 0.1-0.2 cm, Wow;
With respect to 100 parts by weight of the purified water,
5-8 parts by weight of calendula extract, 4-6 parts by weight of white mushroom extract, 3-5 parts by weight of elm extract, 5-8 parts by weight of green tea extract, 3-5 parts by weight of acidic sea bream extract, 3 to 6 parts by weight of hyaluronic acid, and 4-8 parts by weight of an extract of snowballs are contained. A composition for improving or treating atopic dermatitis using purified water obtained from powder and charcoal powder.
상기 정제수 100중량부에 대해 알란토인(Allantoin)을 5-10중량부 더 첨가한 것을 특징으로 하는 생광석분말과 숯분말로부터 얻은 정제수를 이용한 아토피 피부염 개선 또는 치료용 조성물.
The method according to claim 1,
Wherein allantoin is added in an amount of 5-10 parts by weight with respect to 100 parts by weight of the purified water, and purified water obtained from the powder of charcoal and charcoal powder is used for improving or treating atopic dermatitis.
상기 정제수 100중량부에 대해 꽃다지 추출액을 4-8중량부 더 첨가한 것을 특징으로 하는 생광석분말과 숯분말로부터 얻은 정제수를 이용한 아토피 피부염 개선 또는 치료용 조성물.
The method according to claim 1,
The composition for improving or treating atopic dermatitis according to claim 1, wherein 4-8 parts by weight of a flower extract is added to 100 parts by weight of the purified water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160045791A KR20170117841A (en) | 2016-04-14 | 2016-04-14 | Improvement or treatment of atopic dermatitis using a purified composition obtained from raw ore powder and charcoal powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160045791A KR20170117841A (en) | 2016-04-14 | 2016-04-14 | Improvement or treatment of atopic dermatitis using a purified composition obtained from raw ore powder and charcoal powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20170117841A true KR20170117841A (en) | 2017-10-24 |
Family
ID=60299631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020160045791A Ceased KR20170117841A (en) | 2016-04-14 | 2016-04-14 | Improvement or treatment of atopic dermatitis using a purified composition obtained from raw ore powder and charcoal powder |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20170117841A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190046096A (en) | 2017-10-25 | 2019-05-07 | (주)예스킨 | Composition for treating atopic dermatitis |
| KR20210009526A (en) * | 2019-07-17 | 2021-01-27 | 주식회사 제이투케이바이오 | A skin-care agent containing hyaluronic acid complex |
-
2016
- 2016-04-14 KR KR1020160045791A patent/KR20170117841A/en not_active Ceased
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190046096A (en) | 2017-10-25 | 2019-05-07 | (주)예스킨 | Composition for treating atopic dermatitis |
| KR20210009526A (en) * | 2019-07-17 | 2021-01-27 | 주식회사 제이투케이바이오 | A skin-care agent containing hyaluronic acid complex |
| US11110117B2 (en) | 2019-07-17 | 2021-09-07 | J2Kbio Co., Ltd. | Skin preparation composition for external use containing complex hyaluronic acid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shahrajabian et al. | Modern pharmacological actions of longan fruits and their usages in traditional herbal remedies | |
| CN104856035A (en) | Health-care product for recuperating specific intrinsic constitution | |
| KR20130029098A (en) | Mathod for manufacturing ion mineral using silk worm, muberry leaf, and muberry twig and health drink manufactured by this | |
| CN110946196B (en) | Mujiang Yeke granules and preparation method thereof | |
| CN101507459A (en) | Olive instant tea and preparation method thereof | |
| CN103349118A (en) | Compound folium mori tea | |
| CN104547045B (en) | A kind of leaf of Moringa compound granules and preparation method thereof | |
| CN104522455A (en) | Saussurea involucrate culture honey cream and preparation method thereof | |
| KR100867514B1 (en) | Manufacturing method of paper soap | |
| KR101798026B1 (en) | Functional composition having blood circulation and atopy-soothing effect | |
| CN109303724A (en) | A kind of novel maintenance stoste composition of releiving containing folium artemisiae argyi | |
| CN104398416A (en) | Tibetan medicine composition and preparation method and application thereof | |
| KR20160001112A (en) | Composition for the treatment and improvement of atopic dermatitis | |
| CN105101981A (en) | Oxidized protein hydrolase activity enhancing agent | |
| CN106107375A (en) | Folium Bambosae flavone extracts and prepares this Folium Bambosae flavone health promoting beverage and the method for beverage | |
| RU2332866C2 (en) | Dietary supplement "perstevit" | |
| KR20170117841A (en) | Improvement or treatment of atopic dermatitis using a purified composition obtained from raw ore powder and charcoal powder | |
| CN101972025A (en) | Bamboo vinegar health care beverage and preparation method thereof | |
| KR20230081343A (en) | Hair and scalp cosmetic composition containing natural fermented extract | |
| CN101869543A (en) | Biological healthy lotion comprising pineapple, papain, shaddock, mugwort leaf extract and pearl | |
| CN105212222B (en) | Join frog oil chewable tablets | |
| CN102308989B (en) | Health care composition of formica rufa, grape and propolis extracts | |
| CN104719912A (en) | Snow lotus culture-honey paste with relatively high biological activity and preparation method of snow lotus culture-honey paste | |
| CN108354879A (en) | A kind of aseptic face cream of anti-acne and preparation method thereof | |
| CN104686886A (en) | Efficient saussurea involucrate culture and honey paste and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20160414 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170228 Patent event code: PE09021S01D |
|
| E90F | Notification of reason for final refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20170531 Patent event code: PE09021S02D |
|
| PG1501 | Laying open of application | ||
| E601 | Decision to refuse application | ||
| E801 | Decision on dismissal of amendment | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20171129 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20170531 Comment text: Final Notice of Reason for Refusal Patent event code: PE06011S02I Patent event date: 20170228 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| PE0801 | Dismissal of amendment |
Patent event code: PE08012E01D Comment text: Decision on Dismissal of Amendment Patent event date: 20171129 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20170726 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20170317 |